FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $296.8 million versus the consensus estimate of $291.73 million.
GUIDANCE:
USANA Health Sciences sees Q4 2018 EPS of $5.00-$5.15, versus... More

